| pubmed-article:15942884 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15942884 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15942884 | lifeskim:mentions | umls-concept:C0024117 | lld:lifeskim |
| pubmed-article:15942884 | lifeskim:mentions | umls-concept:C0536495 | lld:lifeskim |
| pubmed-article:15942884 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:15942884 | pubmed:dateCreated | 2005-6-8 | lld:pubmed |
| pubmed-article:15942884 | pubmed:abstractText | The significant impact of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is now recognized. This recognition has led to increased efforts to provide evidence-based, appropriate treatment of AECOPD, to minimize its negative impact. This article reviews the bacterial etiology of AECOPD and clinical trials (both placebo-controlled and antibiotic comparison trials) that support the use of antibiotics for AECOPD, with an emphasis on the role of newer fluoroquinolones for the treatment of patients with this condition. A discussion of patient stratification that permits identification of those who require initial aggressive antibiotic therapy is presented. | lld:pubmed |
| pubmed-article:15942884 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15942884 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15942884 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15942884 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15942884 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15942884 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15942884 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15942884 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15942884 | pubmed:issn | 1537-6591 | lld:pubmed |
| pubmed-article:15942884 | pubmed:author | pubmed-author:SethiSanjayS | lld:pubmed |
| pubmed-article:15942884 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15942884 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15942884 | pubmed:volume | 41 Suppl 2 | lld:pubmed |
| pubmed-article:15942884 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15942884 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15942884 | pubmed:pagination | S177-85 | lld:pubmed |
| pubmed-article:15942884 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15942884 | pubmed:meshHeading | pubmed-meshheading:15942884... | lld:pubmed |
| pubmed-article:15942884 | pubmed:meshHeading | pubmed-meshheading:15942884... | lld:pubmed |
| pubmed-article:15942884 | pubmed:meshHeading | pubmed-meshheading:15942884... | lld:pubmed |
| pubmed-article:15942884 | pubmed:meshHeading | pubmed-meshheading:15942884... | lld:pubmed |
| pubmed-article:15942884 | pubmed:meshHeading | pubmed-meshheading:15942884... | lld:pubmed |
| pubmed-article:15942884 | pubmed:meshHeading | pubmed-meshheading:15942884... | lld:pubmed |
| pubmed-article:15942884 | pubmed:meshHeading | pubmed-meshheading:15942884... | lld:pubmed |
| pubmed-article:15942884 | pubmed:meshHeading | pubmed-meshheading:15942884... | lld:pubmed |
| pubmed-article:15942884 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15942884 | pubmed:articleTitle | Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease. | lld:pubmed |
| pubmed-article:15942884 | pubmed:affiliation | Division of Pulmonary, Critical Care and Sleep Medicine, State University of New York, and Department of Veterans Affairs, Western New York Healthcare System, Buffalo, New York, USA. ssethi@buffalo.edu | lld:pubmed |
| pubmed-article:15942884 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15942884 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15942884 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:15942884 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15942884 | lld:pubmed |
